Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
Norman J. Siegel New Member Outstanding Science Award
Norman J. Siegel New Member Outstanding Science Award
John Howland Award
John Howland Award
Mary Ellen Avery Award
Mary Ellen Avery Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
PROSPER Diversity Award
PROSPER Diversity Award
ASPN Founders’ Award
ASPN Founders’ Award
David G. Nichols Health Equity Award
David G. Nichols Health Equity Award
ASPN Mid-Career Award
ASPN Mid-Career Award
Awarded Part 4 Maintenance of Certification (MOC) Credit
Awarded Part 4 Maintenance of Certification (MOC) Credit
Poster Icons
Awarded Part 4 Maintenance of Certification (MOC) Credit
Awarded Part 4 Maintenance of Certification (MOC) Credit
ViewAttendees 7

Academic and Research Skills

Clinical Research

Nephrology

Pharmacology and Therapeutics

Trainee

Improving development of therapies: A collaborative approach with the Food and Drug Administration (FDA), industry and academia

Pediatric Drug Development Successes and Failures: The Industry Perspective

Monday, April 28, 2025
9:45am - 10:15am HST
Location:  Convention Center: 316 A

    Speaker(s)

  • Deepa H. Chand, MD, MHSA (she/her/hers)

    Professor of Pediatrics
    University of Illinois College of Medicine
    Bannockburn, Illinois, United States

    Slides
Disclosure(s):
Deepa H. Chand, MD, MHSA: Novartis (Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)